Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer

Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer

IntroductionOvarian cancer recurs in most High Grade Serous Ovarian Cancer (HGSOC) patients, including initial responders, after standard of care. To improve patient survival, we need to identify and understand the factors contributing to early or late recurrence and therapeutically target these mec...

Full description

Bibliographic Details
Main Authors: Nicholas Adzibolosu, Ayesha B. Alvero, Rouba Ali-Fehmi, Radhika Gogoi, Logan Corey, Roslyn Tedja, Hussein Chehade, Vir Gogoi, Robert Morris, Matthew Anderson, Julie Vitko, Clarissa Lam, Douglas B. Craig, Sorin Draghici, Thomas Rutherford, Gil Mor
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Immunology
Subjects:
ovarian cancer
chemoresistance
cold tumors
hot tumors
immune response
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1204148/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1204148/full

Similar Items